Document is current
Any future updates will be listed below
-
Authors
Rytter, Karen https://orcid.org/0000-0001-5700-5599
Hougaard, Anette
Skouboe, Anne Grynnerup
Serifovski, Nermin
Ranjan, Ajenthen Gayathri https://orcid.org/0000-0002-2253-6071
Nørgaard, Kirsten https://orcid.org/0000-0003-1620-8271
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 7 July 2024
First Online: 22 August 2024
Declarations
:
: KR owns shares in Novo Nordisk and has received speaker honorarium from Medtronic. KN holds shares in Novo Nordisk; has been a paid consultant for Novo Nordisk and Medtronic; has received speaker honorarium and honorarium for Advisory Board to her institution from Medtronic, Novo Nordisk, Convatec, and her institution has received research funding from Zealand Pharma, Novo Nordisk, Medtronic, and Dexcom. AH, AGS own shares in Novo Nordisk. NS, AGR have nothing to disclose.
